Keertan Dheda

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

Shabir A. Madhi, Vicky L. Baillie, Clare Cutland et al. · New England Journal of Medicine · 2021 · 1.3K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

Validation of housekeeping genes for normalizing RNA expression in real-time PCR

Keertan Dheda, Jim F. Huggett, Stephen A. Bustin et al. · BioTechniques · 2004 · 1K citations · Full text

Life Sciences, Microbiology, Molecular Biology +10

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

Neel R. Gandhi, Paul Nunn, Keertan Dheda et al. · The Lancet · 2010 · 1K citations

Life Sciences, Infectious Diseases, Microbiology +14